Intuniv 2 mg, Retardtabletten - 84 Swissmedic Key 66130005 Registration Holder Takeda Pharma AG Name Intuniv 2 mg, Retardtabletten Date of registration 15.09.2017 Introduction of Sequence 15.09.2017 ATC-Classification Guanfacine (C02AC02) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 01.10.20. Show package size 84 Index Therapeuticus (Swissmedic) 01.99. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680661300058 Medication Code Synthetika Pharmacode Disponibility
Composition guanfacinum 2 mg ut guanfacini hydrochloridum, hypromellosum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas corresp. natrium 0.071402 mg, polysorbatum 80, cellulosum microcristallinum, silica colloidalis anhydrica, lactosum monohydricum 47.18 mg, povidonum K 30, crospovidonum, glyceroli dibehenas, acidum fumaricum, pro compresso. Packungsbestandteile Galenic Form Delayed release tablets Active Agent Dose Guanfacinum 2 mg
BAG: Active Agent Dose Guanfacinum 2 mg
Inactive agents Dose Acidi Methacrylici Acidum Fumaricum Cellulosum Microcristallinum Crospovidonum Ethylis Acrylatis Polymerisatum Glyceroli Dibehenas Hypromellosum Lactose Monohydrate 47.18 mg Natrii Laurilsulfas Polysorbatum 80 Povidonum K 30 Pro Compresso Silica Colloidalis Anhydrica
Source Data was imported : 03.03.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
